The role of interferon alpha 2b as an adjunctive treatment in the management of aggressive basal cell carcinoma of the eyelids.

Suppr

超能文献

作者信息

Fenton S, Kennedy S, Moriarty P

出版信息

Acta Ophthalmol Scand. 2002 Dec;80(6):674-5. doi: 10.1034/j.1600-0420.2002.800623_3.x.

DOI:10.1034/j.1600-0420.2002.800623_3.x

PMID:12485296

Abstract

摘要

相似文献

The role of interferon alpha 2b as an adjunctive treatment in the management of aggressive basal cell carcinoma of the eyelids.

Acta Ophthalmol Scand. 2002 Dec;80(6):674-5. doi: 10.1034/j.1600-0420.2002.800623_3.x.

Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b.泪小管周围基底细胞癌在采用病灶内注射α-2b干扰素进行初始治疗后可能需要进行手术。

Indian J Ophthalmol. 2008 Jan-Feb;56(1):85-6. doi: 10.4103/0301-4738.37590.

Interferon eyedrops in the treatment of basal cell carcinoma of the eyelid.

Actas Dermosifiliogr. 2014 Mar;105(2):207-8. doi: 10.1016/j.ad.2013.02.006. Epub 2013 Apr 19.

Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.瘤内注射干扰素α-2b治疗基底细胞癌和鳞状细胞癌：再探讨

Dermatol Surg. 2004 Jan;30(1):116-20. doi: 10.1111/j.1524-4725.2004.30020.x.

Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma.病灶内注射干扰素α-2a、α-2b以及两者联合治疗基底细胞癌的效果比较。

J Dermatol. 1996 Jun;23(6):394-6. doi: 10.1111/j.1346-8138.1996.tb04040.x.

Imiquimod in the treatment of eyelid basal cell carcinoma.咪喹莫特治疗眼睑基底细胞癌。

Acta Ophthalmol Scand. 2007 Aug;85(5):566-8. doi: 10.1111/j.1600-0420.2007.00896.x. Epub 2007 Mar 22.

Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.5%咪喹莫特乳膏治疗眼睑结节性基底细胞癌的免疫疗法。

Am J Ophthalmol. 2005 Dec;140(6):1136-9. doi: 10.1016/j.ajo.2005.06.057.

[New chemical preparation plumfain used in the treatment of patients with malignant neoformations of the eyelids and eyeball].[用于治疗眼睑和眼球恶性新生物患者的新型化学制剂普卢姆芬]

Oftalmol Zh. 1979;34(5):297-9.

Treatment of basal cell carcinoma with intralesional interferon.病灶内注射干扰素治疗基底细胞癌。

Australas J Dermatol. 1994;35(1):47. doi: 10.1111/j.1440-0960.1994.tb01803.x.

Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.维莫德吉（Erivedge）治疗累及眼眶及眼周区域的基底细胞癌的疗效

Ophthalmic Plast Reconstr Surg. 2015 Nov-Dec;31(6):463-6. doi: 10.1097/IOP.0000000000000388.

引用本文的文献

Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids.特殊部位（唇部和眼睑）皮肤癌治疗中的局部和病灶内免疫疗法

Cancers (Basel). 2023 Oct 17;15(20):5018. doi: 10.3390/cancers15205018.

Presence of interferon regulatory factor-1 in aggressive and nonaggressive histological variants of Basal cell carcinoma specimens.基底细胞癌标本侵袭性和非侵袭性组织学变体中干扰素调节因子-1的存在情况。

J Cutan Aesthet Surg. 2010 Jan;3(1):34-7. doi: 10.4103/0974-2077.63395.

Topical treatment options for conjunctival neoplasms.结膜肿瘤的局部治疗选择。

Clin Ophthalmol. 2008 Sep;2(3):503-15. doi: 10.2147/opth.s1606.

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.用干扰素协同制剂治疗晚期、复发性、对先前治疗耐药的基底细胞和鳞状细胞皮肤癌。开放性前瞻性研究。

BMC Cancer. 2009 Jul 30;9:262. doi: 10.1186/1471-2407-9-262.

Indian J Ophthalmol. 2008 Jan-Feb;56(1):85-6. doi: 10.4103/0301-4738.37590.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验